Eastman Chemical Company
NYSE:EMNChemicals
-$1.16 today
- Market cap
- $7.13B
- Beta
- 1.07
- P/E (TTM)
- 20.6
- EPS (TTM)
- $3.50
- Dividend yield
- 4.65%
Volume 1.38M
Average 1.33M
EMN Other Investing Activities
Investing cash flows not reported separately.
Eastman Chemical CompanyNYSE: EMN
Other Investing Activities · Q2 FY2026 · quarter ended Jun 2026
Other investing activities declines year over year
Q2 FY2026 other investing activities of $1M fell 66.7% year over year, behind the -41.3% change in trailing-twelve-month other investing activities. Over 3 fiscal years it compounded at +97.2% a year.
Context
- Other investing activities amounted to 0.5% of revenue in FY2025, up 0.2 pp from a year earlier.
- Other investing activities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -66.7% toward the trailing-twelve-month pace of -41.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Investing Activities history
USD · from the cash flow
- Latest · FY2025
- 46M USD
- Year-over-year change
- +70.4%
| Period | Period end | Other Investing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 46M | +70.4% |
| FY2024 | 2024-12-31 | 27M | +58.8% |
| FY2023 | 2023-12-31 | 17M | +183.3% |
| FY2022 | 2022-12-31 | 6M | +122.2% |
| FY2021 | 2021-12-31 | (27M) | — |
Other Investing Activities vs competitors
How EMN compares with its peers on the latest reported figures
- EMN's LTM Jun 2026 other investing activities of $27M is the 6th largest of the 11 companies compared; the peer median is $8.3M.
- Its year-over-year change of -41.3% is the 7th highest of 10, against a peer median of +126.9%.
- Other investing activities amounts to 0.3% of revenue for EMN, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $867.4M | -345.0% | — | 24.9% | |
| LTM Sep 2026 | $250M | +156.2% | -83.5% | 0.6% | |
| LTM Sep 2026 | $72M | +148.3% | -9.1% | 0.6% | |
| LTM Mar 2026 | $65M | +181.1% | +29.7% | 2.8% | |
| LTM Jun 2026 | $34M | -17.1% | -79.2% | 1.8% | |
| LTM Jun 2026 | $27M | -41.3% | +97.2% | 0.3% | |
| LTM Sep 2026 | $9.6M | — | -54.1% | 0.3% | |
| LTM Jun 2026 | $7M | +126.9% | — | 0.2% | |
| LTM Sep 2026 | $4.6M | +141.4% | — | 0.4% | |
| LTM Jun 2026 | $1.6M | -88.7% | +137.5% | 0.1% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding EMN) | $8.3M | +126.9% | -31.6% | 0.5% | |
Competitors are the stored peer set for EMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 867M | 796M | 896M | 908M | 474M |
| Depreciation & Amortization | 538M | 477M | 498M | 509M | 513M |
| Deferred Income Tax | (38M) | (136M) | (102M) | (52M) | 141M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (27M) | 13M | 291M | (29M) | (186M) |
| Accounts Receivables | (281M) | 93M | 126M | 28M | 61M |
| Inventory | (389M) | (430M) | 201M | (344M) | 24M |
| Accounts Payables | 554M | 60M | (190M) | 188M | (76M) |
| Other Working Capital | 89M | 290M | 154M | 99M | (195M) |
| Other Non-Cash Items | 279M | (175M) | (209M) | (49M) | 28M |
| Operating Cash Flow | 1.62B | 975M | 1.37B | 1.29B | 970M |
| Capital Expenditures | (578M) | (611M) | (828M) | (599M) | (546M) |
| Acquisitions (Net) | 553M | 997M | 379M | 38M | 38M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (27M) | 6M | 17M | 27M | 46M |
| Investing Cash Flow | (29M) | 392M | (432M) | (534M) | (462M) |
| Debt Repayment | (350M) | 76M | (338M) | 198M | (304M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (1B) | (1B) | (150M) | (300M) | (100M) |
| Dividends Paid | (375M) | (381M) | (376M) | (379M) | (381M) |
| Other Financing Activities | 35M | (14M) | (24M) | 27M | (12M) |
| Financing Cash Flow | (1.69B) | (1.32B) | (888M) | (454M) | (797M) |
| Effect of Forex Changes | (5M) | (12M) | 1M | (10M) | 18M |
| Net Change in Cash | (105M) | 34M | 55M | 289M | (271M) |
| Free Cash Flow | 1.04B | 364M | 546M | 688M | 424M |
Eastman Chemical Company
NYSE:EMN
Intrinsic Alpha fair value
Locked
Current Price
$62.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.